"Yeah, but for every successful drug there are probably several unsuccessful ones. The good ones have to pay for the bad. In any case, I think we both understand that pharmaceuticals are a special case, which probably warrant their own discussion."
There is that to take into account. But yes. I think it would be best to leave Pharmaceuticals to another discussion. As they do bear some special considerations.
An interesting solution to copyright in general. (Though a bureaucratic nightmare) Would be to have patents last until a 5% ROI is achieved, or 20 years. Whatever comes first.
The problem with that solution, besides tracking how each and every patent is progressing, would be it encourages patent trolling, by just sitting on a patent so it lasts for forever, additionally, it delays scientists from learning from the mistakes of others, instead of just being able to replicate the successes.
Overall this is why I support a short copyright, as it allows faster innovation from all fronts, due to increased access to information.
Yeah, technology based knowledge, among a few other things was in the forefront of my mind, as one of the realms that lasts far too long.